Literature DB >> 14988630

Ventricular assist devices as a bridge to transplant or recovery.

Aftab R Kherani1, Simon Maybaum, Mehmet C Oz.   

Abstract

Ventricular assist devices have emerged as the standard of care in treating end-stage heart failure. Their success in bridging patients to transplantation is well documented. The data supporting their ability to bridge patients to recovery is sparser. However, as technology continues to advance, these devices will offer a high quality of life both in and out of the hospital setting, making them options for a broader spectrum of heart failure patients. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 14988630     DOI: 10.1159/000075989

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  2 in total

1.  Dynamic changes in lymphocyte GRK2 levels in cardiac transplant patients: a biomarker for left ventricular function.

Authors:  Raphael E Bonita; Philip W Raake; Nicholas J Otis; J Kurt Chuprun; Talya Spivack; Abhijit Dasgupta; David J Whellan; Paul J Mather; Walter J Koch
Journal:  Clin Transl Sci       Date:  2010-02       Impact factor: 4.689

2.  Left ventricular assist device (LVAD) program in Chile: first successful experience in South America.

Authors:  Oneglio Pedemonte; Andres Vera; Lorenzo Merello; Manuel Novajas; Fernando Aranda; Julio Ibarra; Jose A Muñoz; Javier Alburquerque; Paulina Espinoza; Felipe Cárdenas; Ernesto Aránguiz-Santander
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.